Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 5 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.

Anaemia linked to HbA1c concentrations

22 Oct 2019

Different types of anaemia have varied effects on glycated haemoglobin (HbA1c) levels, a new study has found. In nonanaemic individuals, haemoglobin has an inverse correlation with HbA1c.

Accessing health check-up data from 36,422 nondiabetic workers from Japan, researchers identified those with anaemia and divided them into three groups according to mean corpuscular volume (MCV): <80, 80–90 and >90 fL. Nonanaemic participants were grouped into four based on haemoglobin concentrations.

The prevalence rates of anaemia with MCV <80, 80–90 and >90 fL in males were 0.2 percent, 0.5 percent and 0.9 percent, respectively; 98.4 percent had no anaemia. The corresponding rates in females were 6.1 percent, 6.4 percent and 2.8 percent, with 84.7 percent having no anaemia.

After controlling for age, body mass index, fasting plasma glucose, smoking and place of work, researchers found that both males and females who had anaemia with MCV <80 and 80–90 fL had elevated mean HbA1c levels relative to their nonanaemic counterparts. In contrast, those with anaemia with MCV >90 fL showed lower adjusted HbA1c compared with those who did not have anaemia.

Moreover, HbA1c levels were lower in anaemic participants with MCV >90 fL than in those with MCV <80 or 80–90 fL.

In absolute terms, the difference in HbA1c between males with anaemia with MCV >90 fL and those with preanaemia was –0.05 percent. The same comparison in females yielded an absolute difference of –0.07 percent.

In participants without anaemia, HbA1c shared an inverse association with haemoglobin in males and females (p-trend<0.001 for both). These interactions remained significant after adjusting for potential confounders.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 5 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.